Last reviewed · How we verify

NCT05780931: AMD

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Not yet recruiting Last updated 9 January 2026
What this trial tests

trial testing Study-specific rehabilitation (SSR) procedures in Age-related Macular Degeneration (AMD) in 20 participants. Not yet recruiting.

Timeline
1 March 2026
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorVA Office of Research and Development
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment20
Start date1 March 2026
Primary completion30 June 2026
Estimated completion30 June 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

50 and older, any sex, with Age-related Macular Degeneration (AMD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will help develop new methods of rehabilitating Veterans with vision loss due to Age-related macular degeneration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Age-related Macular Degeneration (AMD)

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05780931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing